Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...
Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results ...
Efficacy outcomes 12 months after initiation of darolutamide ... testing and poly (ADP-ribose) polymerase inhibitor (PARPi) treatment of patients with metastatic castration resistant prostate cancer ...
OCOG-RATIONAL: A phase II randomized trial of optimal recurrence-directed therapy (RDT) without or with androgen-deprivation therapy (ADT) in radio-recurrent oligo-metastatic castrate sensitive ...
The Bombay High Court bench of Justice Somasekhar Sundaresan has held that when there is an ambiguity in the agreement with respect to arbitration related provisions, the business efficacy test ...
In other situations, benefits were unclear or limited. Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic review from the ...
Furthermore, FBXW7 has been demonstrated to enhance the efficacy of immunotherapy by targeting the degradation of specific proteins, as compared to the inactivated form of FBXW7. Additionally, other F ...
PARPi may increase expression of cell death receptor ligands ... The combination of DDRi with DNA-damaging agents has improved the efficacy of these agents in certain contexts. It is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results